Peripheral Exudative Hemorrhagic Chorioretinopathy with and without treatment-Clinical and multimodal imaging characteristics and prognosis.

ABSTRACT:

Purpose

To describe clinical and imaging characteristics of patients with Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR), prognosis and treatment response.

Methods

In this retrospective cohort study medical records of patients diagnosed with PEHCR in a tertiary medical center between 2008 and 2018 were reviewed. Collected data included demographics, medical history, ophthalmologic examination and multi-modal imaging including fundus autofluorescence, optical coherence tomography (OCT), ultrasound (US), fluorescein angiography and indocyanine green angiography when available. Bevacizumab treatment results were analyzed when applied.

Results

35 eyes of 32 patients were included, with a female predominance (56.25%) and an average age of 79.0±9.87 years at pre

SUBMITTER: Safir M 

PROVIDER: S-EPMC9514609 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature